Cwm, LLC Aldeyra Therapeutics, Inc. Put Options Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALDX
# of Institutions
144Shares Held
39MCall Options Held
620KPut Options Held
435K-
Perceptive Advisors LLC New York, NY9.28MShares$48.2 Million2.23% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$28.5 Million21.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$19.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.8 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$9.1 Million2.26% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $303M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...